Corphedra (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Corphedra drug offered from Par Pharmaceutical, Inc.. This alpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | Ephedrine Sulfate |
| SUBSTANCE NAME: | EPHEDRINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | alpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-02-16 |
| END MARKETING DATE: | 0000-00-00 |
Corphedra HUMAN PRESCRIPTION DRUG Details:
| Item Description | Corphedra from Par Pharmaceutical, Inc. |
| LABELER NAME: | Par Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2017-02-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42023-196_2f07b040-7bb7-4587-9aa0-8f826306f346 |
| PRODUCT NDC: | 42023-196 |
| APPLICATION NUMBER: | NDA208943 |
Other EPHEDRINE SULFATE Pharmaceutical Manufacturers / Labelers:
